Home | Cancers | Lung Cancer

Lung Cancer

FDA approves Keytruda for advanced non-small cell lung cancer

First drug approved in lung cancer for patients whose tumors express PD-L1 ...

Doctors often overtreat with radiation in late-stage lung cancer

Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute. ... Full story

COPD heightens deadly lung cancer risk in smokers

Boston, MA ─ Smokers who have chronic obstructive pulmonary disorder (COPD) may face nearly twice the risk of getting small cell lung cancer (SCLC)—the deadliest form of lung cancer—than smokers who don’t have COPD, according to a large worldwide study led by researchers at the Harvard T.H. Chan School of Public Health. ... Full story

Early recall rates decline after second round of lung cancer screening

Scientists at the German Cancer Research Center have published results from the “Lung Cancer Screening Intervention Trial” (LUSI): The early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, but emphasizes the need to have an organized screening program with the baseline scan available for comparison. ... Full story

University collaboration for early detection of lung cancer

The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease. ... Full story

Long telomere length associated with increased lung cancer risk

Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk ... Full story

Overcoming why a new treatment is resisted by lung cancer

A promising agent for the treatment of cancer has so far had little effect on the most common lung tumours, but new research from The University of Manchester has suggested how this resistance might be overcome. ... Full story

Immune Cells Recruited to Support Lung Cancer Growth Could Offer New Drug Targets

Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, researchers from Weill Cornell Medical College found in a new study. Their discovery sheds light on how tumors establish a microenvironment that enables them to flourish, and may offer an effective new target for anti-cancer drugs. ... Full story

Women’s lung cancer cases hit 20,000

Cases of lung cancer in women have reached 20,000 a year in the UK for the first time since records began, according to new Cancer Research UK statistics*. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 159 | displaying: 1 - 10